The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

Erratum for Wiszniewski et al., J Immunol 167 (3) 1787-1794.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiszniewski, W.
Right arrow Articles by Lisowska-Grospierre, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wiszniewski, W.
Right arrow Articles by Lisowska-Grospierre, B.
The Journal of Immunology, 2002, 169: 607.
Copyright © 2002 by The American Association of Immunologists

Mutation in the Class II trans-Activator Leading to a Mild Immunodeficiency

Wojciech Wiszniewski, Marie-Claude Fondaneche, Françoise Le Deist, Maria Kanariou, Françoise Selz, Nicole Brousse, Viktor Steimle, Giovanna Barbieri, Catherine Alcaide-Loridan, Dominique Charron, Alain Fischer and Barbara Lisowska-Grospierre


   Introduction
Top
 Introduction
 
Wojciech Wiszniewski, Marie-Claude Fondaneche, Françoise Le Deist, Maria Kanariou, Françoise Selz, Nicole Brousse, Viktor Steimle, Giovanna Barbieri, Catherine Alcaide-Loridan, Dominique Charron, Alain Fischer, and Barbara Lisowska-Grospierre. Mutation in the Class II trans-Activator Leading to a Mild Immunodeficiency. The Journal of Immunology 2001;167:1787–1794.

The authors found in Figure 5 that wild-type EGFP-CIITA had been used inadvertently for immunofluorescence localization instead of the L469P mutant. They found the bona fide CIITA-L469P is localized predominantly in the cytoplasm; however, it also transits through the nucleus since it shows strong nuclear accumulation after leptomycin treatment. Residual nuclear localization of CIITA-L469P is also found by biochemical analysis of the patient fibroblasts subcellular fractions and is supported by the residual transactivation potential of CIITA-L469P. The main findings and conclusions of the paper remain unchanged.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiszniewski, W.
Right arrow Articles by Lisowska-Grospierre, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wiszniewski, W.
Right arrow Articles by Lisowska-Grospierre, B.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS